or Try an Advanced Search...

    Technical Analysis for AWH - Aspira Women's Health Inc.

    Grade Last Price % Change Price Change
    F 2.66 0.76% 0.02
    AWH closed up 0.76 percent on Friday, May 17, 2024, on 1.98 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical AWH trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    NR7-2 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    NR7 Range Contraction 0.76%
    Lower Bollinger Band Walk Weakness 0.76%
    Stochastic Reached Oversold Weakness 0.76%
    Earnings Movers Other 0.76%
    Older End-of-Day Signals for AWH ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Lower Bollinger Band 1 day ago
    2x Volume Pace 1 day ago
    1.5x Volume Pace 1 day ago
    Fell Below Previous Day's Low 1 day ago
    Up 2% 1 day ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    AWH Chart by TradingView
    Basic chart:

    Profile

    Aspira Women’s Health Inc. (formerly known as Vermillion, Inc. Nasdaq: VRML) is transforming women’s health with the discovery, development, and commercialization of innovative testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women. OVA1®plus combines our FDA-cleared products OVA1® and OVERA® to detect the risk of ovarian malignancy in women with adnexal masses. ASPiRA GenetiXSM testing offers both targeted and a more comprehensive genetic testing options with a gynecologic focus. Our focus is on delivering products that allow healthcare providers to stratify risk, facilitate early detection, and optimize treatment.
    Classification
    Sector: Healthcare
    Industry: Diagnostics & Research
    Keywords: Medicine Clinical Medicine Oncology Healthcare Providers FDA Ovarian Cancer Genetic Testing Patient Management Analytical Solutions Gynaecological Cancer Gynaecology

    Is AWH a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 8 UPDATE -- Aspira Women’s Health to Announce First Quarter Earnings Results and Host a Conference Call on Wednesday, May 15
    May 8 Aspira Women’s Health to Announce First Quarter Earnings Results and Host a Conference Call on Wednesday, May 15
    May 7 Aspira Women’s Health Announces Publication of Two OvaWatch Peer-Reviewed Manuscripts
    Apr 9 Aspira Women’s Health Announces Anthem Blue Cross to Provide Coverage for OvaSuite(SM) in California
    Apr 5 Aspira Women's Health files to sell 1.57M shares for holders
    Mar 28 Aspira Women’s Health GAAP EPS of -$0.30 beats by $0.15, revenue of $2.13M misses by $0.42M
    Mar 28 Aspira Women's Health Inc. (AWH) Q4 2023 Earnings Call Transcript
    Mar 28 Aspira Women’s Health Reports Fourth Quarter and Full Year 2023 Financial Results
    Mar 28 Earnings Scheduled For March 28, 2024
    Mar 25 Aspira Women’s Health Announces New Time for its Fourth Quarter and 2023 Year End Earnings Results and Call
    See more AWH news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 6.75
    52 Week Low 2.3087
    Average Volume 24,639
    200-Day Moving Average 4.00
    50-Day Moving Average 3.25
    20-Day Moving Average 3.11
    10-Day Moving Average 2.90
    Average True Range 0.27
    RSI (14) 28.06
    ADX 27.79
    +DI 11.43
    -DI 22.04
    Chandelier Exit (Long, 3 ATRs) 2.75
    Chandelier Exit (Short, 3 ATRs) 3.44
    Upper Bollinger Bands 3.59
    Lower Bollinger Band 2.62
    Percent B (%b) 0.04
    BandWidth 31.36
    MACD Line -0.17
    MACD Signal Line -0.13
    MACD Histogram -0.0451
    Fundamentals Value
    Market Cap 27.5 Million
    Num Shares 10.3 Million
    EPS -1.66
    Price-to-Earnings (P/E) Ratio -1.60
    Price-to-Sales 5.42
    Price-to-Book 5.02
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.81
    Resistance 3 (R3) 2.82 2.77 2.79
    Resistance 2 (R2) 2.77 2.73 2.77 2.78
    Resistance 1 (R1) 2.71 2.71 2.74 2.71 2.77
    Pivot Point 2.67 2.67 2.68 2.67 2.67
    Support 1 (S1) 2.61 2.63 2.64 2.61 2.55
    Support 2 (S2) 2.57 2.60 2.56 2.54
    Support 3 (S3) 2.51 2.57 2.53
    Support 4 (S4) 2.51